Cardiac resynchronization therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==[[Cardiac resynchronization therapy indications|Indications]]== | ==[[Cardiac resynchronization therapy indications|Indications]]== | ||
:[[Cardiac resynchronization therapy landmark trials|Landmark Trials]] | : Supportive Trial Data | [[Cardiac resynchronization therapy landmark trials|Landmark Trials]] | ||
:'''[[Cardiac resynchronization therapy special populations|Special Populations]]''': [[Cardiac resynchronization therapy special populations#Atrial Fibrillation and CRT|Atrial Fibrillation Patients]] | [[Cardiac resynchronization therapy special populations#Cardiac Resynchronization Therapy in Minimal Heart Failure|Minimal Heart Failure Patients]] | :'''[[Cardiac resynchronization therapy special populations|Special Populations]]''': [[Cardiac resynchronization therapy special populations#Atrial Fibrillation and CRT|Atrial Fibrillation Patients]] | [[Cardiac resynchronization therapy special populations#Cardiac Resynchronization Therapy in Minimal Heart Failure|Minimal Heart Failure Patients]] | ||
Revision as of 16:16, 13 September 2011
|
Cardiac resynchronization therapy Microchapters |
|
Treatment |
|---|
|
Cardiac resynchronization therapy On the Web |
|
American Roentgen Ray Society Images of Cardiac resynchronization therapy |
|
Directions to Hospitals Administering Cardiac resynchronization therapy |
|
Risk calculators and risk factors for Cardiac resynchronization therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:: Bhaskar Purushottam, M.D. [2] Synonyms and Keywords: CRT
Overview
Indications
- Supportive Trial Data | Landmark Trials
- Special Populations: Atrial Fibrillation Patients | Minimal Heart Failure Patients